A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%

Inclusion Criteria: * Sign Informed Consent document. * Diagnosis of open-angle glaucoma or ocular hypertension * Other protocol-specified inclusion criteria may apply. Exclusion Criteria: * Females of childbearing potential if pregnant, lactating, or not using highly effective birth control measures. * Severe central vision loss in either eye. * Any chronic or recurrent inflammatory eye disease. * Ocular trauma within the preceding 6 months. * Ocular infection or ocular inflammation within the preceding 3 months. * Best-corrected visual acuity score worse than 55 letters using the Early Treatment Diabetic Retinopathy Study chart. * Any intraocular surgery within the preceding 6 months. * Any ocular laser surgery within the preceding 3 months. * History or current evidence of severe illness or any other conditions which would make the subject, in the opinion of the Investigator, unsuitable for the study. * Other protocol-defined exclusion criteria may apply.